REFERENCE
Sander B, Kwong J, Bauch C, Maetzel A, McGeer A, Raboud J, Krahn M.The cost-effectiveness of Ontario's universal influenza immunization program. 7th World Congress of the International Health Economics Association: abstr. 690, 13 Jul 2009. Available from: URL: http://ihea2009.abstractbook.org
Kou U, Clark A, Wolfson L, Mulholland K.Cost-effectiveness of Haemophilus influenza type B vaccine in low and middle income countries. 7th World Congress of the International Health Economics Association: abstr. 838, 15 Jul 2009. Available from: URL: http://ihea2009.abstractbook.org
Lee V, Tok MY, Chen M, Chow V, Phua KH, Ooi EE.Economic analysis of pre-pandemic influenza vaccination strategies in Singapore. 7th World Congress of the International Health Economics Association: abstr. 1576, 12 Jul 2009. Available from: URL: http://ihea2009.abstractbook.org
de Greeff S, Lugnér A, Mooi F, Melker H.Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. 7th World Congress of the International Health Economics Association: abstr. 590, 14 Jul 2009. Available from: URL: http://ihea2009.abstractbook.org
Milne R, Grimwood K.Economic evaluation of a pentavalent rotavirus vaccine in New Zealand. 7th World Congress of the International Health Economics Association: abstr. 1190, 12 Jul 2009. Available from: URL: http://ihea2009.abstractbook.org
Garrison L, Bauch C, Bresnahan B, Hazlet T, Kadiyala S, Veenstra D.A global cost-effectiveness evaluation of the impact of potential innovations in measles vaccination. 7th World Congress of the International Health Economics Association: abstr. 1273, 14 Jul 2009. Available from: URL: http://ihea2009.abstractbook.org
Rights and permissions
About this article
Cite this article
Vaccine news from the 7th World Congress of the IHEA. Pharmacoecon. Outcomes News 583, 5 (2009). https://doi.org/10.2165/00151234-200905830-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905830-00010